Премини към основното съдържание
Home
language-selector-globe Bulgaria | bg
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Bulgaria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • За нас 
      • Новартис в България 
      • Нашата стратегия 
        • Иновативни лекарства 
      • Хора и Култура 
      • Контакти 
      За нас За нас
    • Пациенти и болногледачи 
      • Аз само да попитам: твоят здравен консултант 
      • Ангажиментът на Новартис към пациентите и лицата, които се грижат за тях 
      • Съобщаване на нежелани реакции 
      • Аз само да попитам: твоят здравен портал 
      Пациенти и болногледачи Пациенти и болногледачи
    • Здравни специалисти 
      • Материали за здравни специалисти 
      • Новартис проекти 
      • Съобщаване на нежелани реакции 
      • Клинични проучвания на Новартис 
      Здравни специалисти Здравни специалисти
    • ESG 
      • Етика, Риск и Законосъобразност 
      • Разширяване на достъпа до здравеопазване 
      • Опазване на природата 
      • Световно здраве 
      • Етично поведение 
        • Етичен кодекс 
        • SpeakUp 
      Околна среда, социални и правни въпроси ESG
    • Новини 
      • Медийни контакти 
      • Новини 
      Новини Новини
    • Кариера 
      • Търсене на кариера 
      • Награди и признание 
      Кариера Кариера
    • Коронавирус 
      Коронавирус Коронавирус
    Новартис България Начало
  1. Начало
  2. Кариера
  3. Търсене на кариера
  • Sort by Sort ascending
  • Длъжност
  • Място
  • Местоположение
  • дивизия Sort descending
  • Бизнес
  • Functional Area
  • Дата
Длъжност Място Местоположение дивизия Sort descending Бизнес Functional Area Дата
ERP Assurance Senior Consultant-2 INSURGENTES Mexico Finance CTS Audit & Finance Авг. 20, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Авг. 22, 2024
R2R Accountant Moscow (City) Russian Fed. Finance CTS Audit & Finance Окт. 22, 2024
Treasury Manager Moscow (City) Russian Fed. Finance CTS Audit & Finance Юни 20, 2024
Order Management Specialist - Temporary INSURGENTES Mexico Finance CTS Audit & Finance Септ. 25, 2024
Global FC&C Process Expert (Senior Manager) PIN-PCA Prague Czech Republic Finance CTS Audit & Finance Окт. 03, 2024
P2P Service Delivery (SD) Lead NGSC INSURGENTES Mexico Finance CTS Audit & Finance Окт. 07, 2024
Finance Control and Compliance US Manager INSURGENTES Mexico Finance CTS Audit & Finance Окт. 08, 2024
General Accounting Manager INSURGENTES Mexico Finance CTS Audit & Finance Окт. 09, 2024
Procure to Pay Business Partner Management INSURGENTES Mexico Finance CTS Audit & Finance Окт. 16, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Japan Finance CTS Audit & Finance Окт. 06, 2024
Vodja Finančne skladnosti in kontrol Slovenija (m/ž/d) / Financial Control and Compliance Lead Slovenia (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Окт. 17, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit & Finance Окт. 17, 2024
Alternant CONTRÔLE DE GESTION - BPA Paris Headquarter (Novartis Pharma S.A.S.) France Finance Innovative Medicines Others Май 17, 2024
Procure to Pay Senior Specialist MR11 INSURGENTES Mexico Finance CTS Audit & Finance Юли 23, 2024
Order to Cash Radioligand Therapy Sr. Specialist INSURGENTES Mexico Finance CTS Audit & Finance Авг. 06, 2024
Record to Report Specialist INSURGENTES Mexico Finance CTS Audit & Finance Септ. 05, 2024
BPA & R2R Analyst Amsterdam Netherlands Finance Innovative Medicines Audit & Finance Септ. 04, 2024
R2R Senior Specialist Bucuresti Romania Finance CTS Audit & Finance Септ. 05, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit & Finance Септ. 06, 2024
Corporate Tax Manager Amiria Egypt Finance Corporate Audit & Finance Май 31, 2024
P2P & T&E Specialist (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Юни 05, 2024
P2P & T&E Business Partner (Japanese speaker) Selangor Malaysia Finance CTS Audit & Finance Юни 12, 2024
R2R Senior Specialist GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Юни 13, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit & Finance Юни 20, 2024
Senior Financial Reporting and Accounting Specialist Prague Czech Republic Finance CTS Audit & Finance Юли 03, 2024
Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Юли 22, 2024
P2P & T&E Specialist (Arabic Speaker) Selangor Malaysia Finance CTS Audit & Finance Юли 05, 2024
R2R Senior Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Окт. 02, 2024
Site Finance Head Morris Plains USA Finance Innovative Medicines Audit & Finance Окт. 04, 2024
Senior FRA Specialist GL Prague Czech Republic Finance CTS Audit & Finance Септ. 26, 2024
Comptable Général(e) Expérimenté(e) H/F Paris Headquarter (Novartis Pharma S.A.S.) France Finance CTS Audit & Finance Септ. 27, 2024
R2R Senior Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Окт. 08, 2024
Expert Analyst – Management Reporting Prague Czech Republic Finance Corporate Audit & Finance Окт. 08, 2024
Global Finance Master Data Sr Specialist INSURGENTES Mexico Finance CTS Audit & Finance Окт. 08, 2024
Record to Report (R2R) Specialist New Cairo Egypt Finance CTS Audit & Finance Окт. 18, 2024
Record to Report (R2R) Section Head New Cairo Egypt Finance CTS Audit & Finance Окт. 18, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Окт. 15, 2024
FRA Analyst Treasury and Cash Management / Analitik - specialist Ljubljana Slovenia Finance CTS Audit & Finance Окт. 15, 2024
Treasury Cash Management Payment Specialist INSURGENTES Mexico Finance CTS Audit & Finance Окт. 16, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Юли 28, 2024
Tax Specialist Mumbai (Head Office) India Finance Corporate Audit & Finance Окт. 20, 2024
LDC Solution Design Manager RDF Prague Czech Republic Finance CTS Audit & Finance Окт. 21, 2024
Finančni analitik poslovnega planiranja in analiz (m/ž/d) / BPA Finance Analyst (m/f/d) Ljubljana Slovenia Finance Innovative Medicines Audit & Finance Окт. 21, 2024
R2R Team Lead - GL & Reporting Selangor Malaysia Finance CTS Audit & Finance Окт. 10, 2024
BPA (Budget & Planning Analyst) İstanbul Kurtköy Turkey Finance Innovative Medicines Audit & Finance Окт. 10, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spain Finance Corporate Audit & Finance Окт. 22, 2024
Senior Financial Analyst - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Окт. 22, 2024
Analitik (m/ž/d) / FRA Analyst (m/f/d) Ljubljana Slovenia Finance CTS Audit & Finance Окт. 23, 2024
Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Окт. 23, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 42
  • › Next page

Новартис България

Навигация
  • Пациенти и болногледачи
  • Здравни специалисти
  • ESG
  • Новини
  • Кариера
Медиен център
  • Архив
  • Новини
Нашето портфолио
  • Клинични проекти на Новартис
Други сайтове на Новартис
  • Глобален сайт
Footer Bottom
© 2024 Новартис АГ
  • Политика за поверителност
  • Условия на ползване
  • Достъп от мрежата
  • Настройки за бисквитки
  • Навигация на сайта
Директория на сайта на Новартис
Тази страница е предназначена за обществеността в България